Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Paid

<< Previous

Bullboard Posts

Next >>

Comment by KVDollarson Nov 15, 2021 10:02am

103 Views

Post# 34126763

RE:RE:Paid

Bangada wrote: Soooon, you said sooooon again. Maybe sooooon the paid hypers will disappear.

Bangada the donkey of the day as usual..

Say when Tetra flew from .20s to 50s last time. You tucked your tail under your legs and hid. Now that its heading to .20s and lower you coming out here trying instill fear

Bangadada, DODNOWm, ELAINOOB, and SAMV21 -- ALL the resident bashers of Tetra

Claim to be share holders , but really just bashing to scare potential investors and they are paid well do it, obviously

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record